Real-world experience with the two-drug regimen dolutegravir and lamivudine in women with HIV: a systematic literature review

被引：0
|
作者：
di Giambenedetto, S. [1 ]
Walmsley, S. [2 ]
Grinsztejn, B. [3 ]
Perez-Elias, M. [4 ]
Nwokolo, N. [5 ]
Kabra, M. [6 ]
Jones, B. [7 ]
Letang, E. [8 ]
Kisare, M. [9 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli Ist Ricovero &, Infect Dis, Rome, Italy
[2] Univ Hlth Network, Infect Dis, Toronto, ON, Canada
[3] Inst Nacl Infectol Evandro Chagas Fiocruz, Infect Dis, Rio De Janeiro, Brazil
[4] Hosp Univ Ramon y Cajal, Infect Dis, Madrid, Spain
[5] ViiV Healthcare, Global Patient Affairs, Brentford, England
[6] ViiV Healthcare, Global Hlth Outcomes, Brentford, England
[7] ViiV Healthcare, Global Med Affairs, Brentford, England
[8] ViiV Healthcare, Global Med Affairs, Madrid, Spain
[9] ViiV Healthcare, Global Med Affairs, Nairobi, Kenya
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P044
引用
收藏
页码：51 / 52
页数：2
相关论文
共 50 条
  • [1] HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review
    Rickesh Patel
    Lee Evitt
    Ilias Mariolis
    Simona Di Giambenedetto
    Antonella d’Arminio Monforte
    José Casado
    Alfonso Cabello Úbeda
    Laurent Hocqueloux
    Clotilde Allavena
    Tristan Barber
    Diwakar Jha
    Rahul Kumar
    Rahul Dinesh Kamath
    Tia Vincent
    Jean van Wyk
    Justin Koteff
    [J]. Infectious Diseases and Therapy, 2021, 10 : 2051 - 2070
  • [2] HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review
    Patel, Rickesh
    Evitt, Lee
    Mariolis, Ilias
    Di Giambenedetto, Simona
    Monforte, Antonella D'Arminio
    Casado, Jose
    Cabello Ubeda, Alfonso
    Hocqueloux, Laurent
    Allavena, Clotilde
    Barber, Tristan
    Jha, Diwakar
    Kumar, Rahul
    Kamath, Rahul Dinesh
    Vincent, Tia
    van Wyk, Jean
    Koteff, Justin
    [J]. INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2051 - 2070
  • [3] Systematic literature review of real-world experience with the two-drug regimen dolutegravir and lamivudine in people with HIV who would not have met inclusion criteria for the phase III clinical program
    Slim, J.
    Ward, D.
    Schneider, S.
    Kabra, M.
    Verdier, G.
    Jones, B.
    Letang, E.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 86 - 88
  • [4] Lipid changes in real-world studies with the two-drug regimen dolutegravir and lamivudine (DTG+3TC) in people with HIV-1: a systematic literature review
    Letang, E.
    Lo, J.
    Milinkovic, A.
    Maggiolo, F.
    di Giambenedetto, S.
    Mussini, C.
    Yoruk, I. Ungan
    Henegar, C.
    Priest, J.
    Young, B.
    Kabra, M.
    Jones, B.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 154 - 156
  • [5] Effectiveness and tolerability of the two-drug regimen dolutegravir plus lamivudine in people with HIV-1: a systematic literature review of real-world evidence from clinical practice
    Letang, Emilio
    Priest, Julie
    Di Giambenedetto, Simona
    Monforte, Antonella d'Arminio
    Casado, Jose
    Cabello-Ubeda, Alfonso
    Hocqueloux, Laurent
    Allavena, Clotilde
    Barber, Tristan J.
    Jha, Diwakar
    Kamath, Rahul Dinesh
    Sithamparanathan, Myooran
    van Wyk, Jean
    Evitt, Lee
    [J]. HIV MEDICINE, 2022, 23 : 37 - 38
  • [6] Real-World Experience with Dolutegravir-Based Two-Drug Regimens
    Ward, Douglas
    Ramgopal, Moti
    Riedel, David J.
    Garris, Cindy
    Dhir, Shelly
    Waller, John
    Roberts, Jenna
    Mycock, Katie
    Oglesby, Alan
    Collins, Bonnie
    Dominguez, Megan
    Pike, James
    Mrus, Joseph
    [J]. AIDS RESEARCH AND TREATMENT, 2020, 2020
  • [7] Drug-drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment
    Cattaneo, Dario
    Capetti, Amedeo
    Rizzardini, Giuliano
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (03) : 245 - 252
  • [8] Dolutegravir/Lamivudine (Dovato) - A Two-Drug Complete Regimen for HIV-1 Infection
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1579): : 134 - 136
  • [9] Impact on inflammatory and atherogenesis biomarkers with the two-drug regimen dolutegravir plus lamivudine in treatment-experienced people with HIV-1: a systematic literature review
    Llibre, Joseph
    Cahn, Pedro E.
    Lo, Janet
    Barber, Tristan J.
    Mussini, Christina
    van Welzen, Berend J.
    Hernandez, Beatriz
    Donovan, Cynthia
    Kisare, Michelle
    Sithamparanathan, Myooran
    van Wyk, Jean
    [J]. HIV MEDICINE, 2022, 23 : 54 - 55
  • [10] Effectiveness and safety of dolutegravir two-drug regimens in virologically suppressed people living with HIV: a systematic literature review and meta-analysis of real-world evidence
    Punekar, Y. S.
    Parks, D.
    Joshi, M.
    Kaur, S.
    Evitt, L.
    Chounta, V
    Radford, M.
    Jha, D.
    Ferrante, S.
    Sharma, S.
    Van Wyk, J.
    de Ruiter, A.
    [J]. HIV MEDICINE, 2021, 22 (06) : 423 - 433
12345